Wilbanks Smith & Thomas Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,700	Closed	-$639K	–	332
2015 Q1	$639K	Hold	3,700	–	–	0.06%	151
2014 Q4	$425K	Hold	3,700	–	–	0.04%	192
2014 Q3	$578K	Hold	3,700	–	–	0.06%	157
2014 Q2	$456K	Hold	3,700	–	–	0.05%	176
2014 Q1	$383K	Hold	3,700	–	–	0.04%	198
2013 Q4	$333K	Hold	3,700	–	–	0.04%	203
2013 Q3	$247K	Hold	3,700	–	–	0.03%	232
2013 Q2	$245K	Buy	+3,700	New	+$212K	0.04%	221

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's SLXP Position: Q2 2015 in Review

Wilbanks Smith & Thomas Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 3,700 shares — an estimated $639K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $639K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Wilbanks Smith & Thomas Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Wilbanks Smith & Thomas Asset Management sold 3,700 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $639K.
Wilbanks Smith & Thomas Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Wilbanks Smith & Thomas Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $639K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q2 2015, filed 21 Jul 2015.